HLNCF Company Profile and Key Details

Haleon plc (OTC:HLNCF) closed at $4.54 USD, losing -$0.01 (-0.22%) from the previous close of $4.54. The stock is currently mid-range between its 52-week high and low $4.15 and $5.75. With a market capitalization of about $39.94 billion, Haleon plc is classified as a large-cap and shows lower-than-market volatility (beta ~0.24). Key stats such as the average daily volume over the past year has been around 5.60 thousand shares, volume is running light vs its 52-week average. Headquartered in Weybridge, SU, Haleon plc operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Brian James McNamara, the company employs approximately 24,561 people and listed since July 28, 2022. Haleon plc operates as a global consumer healthcare enterprise, actively involved in the research, development, production, and distribution of a diverse range of products.

Haleon plc last paid a dividend of 0.1 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $10.02. This means the shares are trading below this model’s fair value.

Average 10-day trading volume of 7.63 thousand shares is slightly above the 3-month average of 6.18 thousand, indicating heightened recent market interest.

Haleon plc earnings surprise history is a mixed track record. The quarter that ended July 30, 2026, missed forecasts by 2.94%. The prior quarter beat by 2.86%. Over the last six quarters, Apple has recorded several small beats. These include -17.77% in May 01, 2024.

Our AI price prediction model suggests that Haleon plc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Haleon plc trading at a premium to the broader market with a P/E of 37.59.

Haleon plc trades at a P/E ratio of 37.59, slightly above the S&P 500 average, with a price-to-sales ratio of 5.39 and a price-to-book ratio of 1.85 suggesting the stock is closer to book value. The P/FCF stands at 12.77, also above market averages.